Erratum: Induced Pluripotent Stem Cells—Derived Stem Cells: A Promising Tool for Disease Modeling
DOI:
https://doi.org/10.17140/GOROJ-9-160Abstract
Erratum
Unfortunately, there was an error in the original version of this article.
The authors wish to delete the following sentence in the conclusion section: For example, in neurological rare metabolic disease, X ALD, there is no genotype phenotype correction and due to inaccessibility of tissue samples, research presents caveats in discovery of biomarkers.
This statement has been now corrected.
The publisher and the author would like to apologise for any inconvenience caused to the readers. The change does not affect the scientific results. The corrected manuscript is updated and the original will remain online on the article webpage.
References
Marchetto MC, Brennand KJ, Boyer LF, Gage FH. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum Mol Genet. 2011; 20(R2): R109-R115. doi: 10.1093/hmg/ddr336
Ebert AD, Liang P, Wu JC. Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Phar-macol. 2012; 60(4): 408-416. doi: 10.1097/FJC.0b013e318247f642
Takahashi K, Yamanaka S. Induction of pluripotent stem cells Submit your article to this journal | https://openventio.org/submit-manuscript/ 10 Parasar P from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676. doi: 10.1016/j.cell.2006.07.024
Li L, Chao J, Shi Y. Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases. Cell Tissue Res. 2018; 371(1): 143-151. doi: 10.1007/s00441-017-2713-x
Liang KX, Kristiansen CK, Mostafavi S, et al. Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mu-tations. EMBO Mol Med. 2020; 12(10): e12146. doi: 10.15252/ emmm.202012146
Joseph R, Bales K, Srivastava K, Srivastava O. Lens epithelial cells-induced pluripotent stem cells as a model to study epithe-lial-mesenchymal transition during posterior capsular opacifi-cation. Biochem Biophys Rep. 2019; 20: 100696. doi: 10.1016/j. bbrep.2019.100696
Lipskind S, Lindsey JS, Gerami-Naini B, et al. An embryonic and induced pluripotent stem cell model for ovarian granulosa cell development and steroidogenesis. Reprod Sci. 2018; 25(5): 712-726. doi: 10.1177/1933719117725814
Cozzolino M, Marin D, Sisti G. New Frontiers in IVF: mtDNA and autologous germline mitochondrial energy transfer. Reprod Biol Endocrinol. 2019; 17(1): 55. doi: 10.1186/s12958-019-0501-z
Gulimiheranmu M, Wang X, Zhou J. Advances in female germ cell induction from pluripotent stem cells. Stem Cells Int. 2021; 2021: 8849230. doi: 10.1155/2021/8849230
Laronda MM, Burdette JE, Kim J, Woodruff TK. Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment. Stem Cell Res Ther. 2013; 4 Suppl 1: S13. doi: 10.1186/scrt374
McTague A, Rossignoli G, Ferrini A, Barral S, Kurian MA. Ge-nome editing in iPSC-based neural systems: From disease models to future therapeutic strategies. Front Genome Ed. 2021; 3: 630600. doi: 10.3389/fgeed.2021.630600 Opinion | Volume 9 | Number 1|
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
